Trials / Completed
CompletedNCT04813731
COVID-19 And Lingering Symptoms In Primary Care Patients
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 300 (actual)
- Sponsor
- Katarina Hedin · Other Government
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
The ongoing corona virus disease 2019 (COVID-19) is a viral acute respiratory tract infection caused by server acute respiratory syndrom coronavirus typ 2 (SARS-CoV-2). The signs and symptom of SARS-CoV-2 infection vary and most people with COVID-19 experience illness of mild or moderate severity and recover with symptomatic treatment outside of hospital. Studies have found that some people experience lingering/long-lasting symptoms and only a minority of patients were completely free from COVID-19 related symptoms after two months. About one third still had up to two residual symptoms and 55% had three or more. As far as we know no study on lingering symptoms has been published in patients after a mild or moderate infection managed in primary care settings. The aim of this study is to explore the course of disease over a one year period and describe lingering symptoms and their impact on well-being and daily activities in adult non-hospitalized patients with previous established COVID-19 infection.
Conditions
Timeline
- Start date
- 2020-12-12
- Primary completion
- 2022-06-30
- Completion
- 2022-06-30
- First posted
- 2021-03-24
- Last updated
- 2025-09-04
Locations
13 sites across 11 countries: Belgium, Denmark, France, Georgia, Germany, Ireland, Italy, Netherlands, Poland, Romania, Sweden
Source: ClinicalTrials.gov record NCT04813731. Inclusion in this directory is not an endorsement.